Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 2,463,000 | 2,544,000 | 2,508,500 | 2,589,100 | 2,531,800 |
Cost of Goods | 662,800 | 570,900 | 469,500 | 484,000 | 753,900 |
Gross Profit | 1,800,200 | 1,973,100 | 2,039,000 | 2,105,100 | 1,777,900 |
Operating Expenses | 1,293,300 | 1,257,100 | 724,400 | 1,264,200 | 1,168,100 |
Operating Income | 507,700 | 716,900 | 1,315,100 | 840,900 | 610,700 |
Other Income | -69,400 | -113,100 | 56,000 | 434,500 | -266,600 |
Pre-tax Income | 438,300 | 603,800 | 1,371,100 | 1,275,400 | 344,100 |
Income Tax | 50,700 | 54,300 | 236,200 | 216,700 | 125,600 |
Net Income Continuous | 387,600 | 549,500 | 1,134,900 | 1,058,700 | 218,500 |
Minority Interests | -300 | -900 | 200 | 700 | -85,300 |
Net Income | $387,900 | $550,400 | $1,134,700 | $1,058,000 | $303,800 |
EPS Basic Total Ops | 2.69 | 3.79 | 7.86 | 7.25 | 2.06 |
EPS Basic Continuous Ops | 2.68 | 3.78 | 7.86 | 7.26 | 1.49 |
EPS Diluted Total Ops | 2.67 | 3.73 | 7.84 | 7.24 | 2.06 |
EPS Diluted Continuous Ops | 2.67 | 3.73 | 7.84 | 7.24 | 1.48 |
EPS Diluted Before Non-Recurring Items | 3.40 | 4.05 | 4.77 | N/A | N/A |
EBITDA(a) | $620,000 | $956,300 | $1,435,800 | $975,700 | $753,800 |